Woodline Partners LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
Zevra Therapeutics, Inc. 13G/A
ZVRA · 488445206
8.1% 8/14/2026
Event 6/30/2026
Tango Therapeutics, Inc. 13G/A
TNGX · 87583X109
2.5% 8/14/2026
Event 6/30/2026
SAB Biotherapeutics, Inc. 13G/A
SABS · 78397T202
6.8% 8/14/2026
Event 6/30/2026
CervoMed Inc. 13G
CRVO · 15713L109
5.1% 8/14/2026
Event 6/30/2026
CalciMedica, Inc. 13G
CALC · 38942Q202
8.1% 8/14/2026
Event 6/30/2026
Black Rock Coffee Bar, Inc. 13G/A
BRCB · 092244102
0% 8/14/2026
Event 6/30/2026
Biohaven Ltd. 13G
BHVN · G1110E107
5.1% 8/14/2026
Event 6/30/2026
BJ's Restaurants, Inc. 13G/A
BJRI · 09180C106
4.6% 5/15/2026
Event 3/31/2026
Quoin Pharmaceuticals, Ltd. 13G/A
QNRX · 74907L409
4.4% 5/15/2026
Event 3/31/2026
Adicet Bio, Inc. 13G/A
ACET · 007002207
3.3% 5/15/2026
Event 3/31/2026
Vishay Intertechnology, Inc. 13G/A
VSH · 928298108
4.0% 5/15/2026
Event 3/31/2026
Outset Medical, Inc. 13G/A
OM · 690145206
1.6% 5/15/2026
Event 3/31/2026
Aligos Therapeutics, Inc. 13G/A
ALGS · 01626L204
4.4% 5/15/2026
Event 3/31/2026
XOMA Royalty Corp 13G
XOMA · 98419J206
5.4% 5/15/2026
Event 3/31/2026
OKYO Pharma LTD 13G
OKYO · G6724L116
7.0% 5/15/2026
Event 3/31/2026
Pliant Therapeutics, Inc. 13G/A
PLRX · 729139105
3.3% 2/17/2026
Event 12/31/2025
Equillium, Inc. 13G
EQ · 29446K106
5.9% 11/14/2025
Event 9/30/2025
AIRO Group Holdings, Inc. 13G/A
AIRO · 009422106
8.5% 11/14/2025
Event 9/30/2025
Sagimet Biosciences Inc. 13G/A
SGMT · 786700104
4.8% 11/14/2025
Event 9/30/2025
Tenaya Therapeutics, Inc. 13G/A
TNYA · 87990A106
4.99% 8/14/2025
Event 6/30/2025
Travere Therapeutics, Inc. 13G/A
TVTX · 89422G107
2.4% 2/14/2025
Event 12/31/2024
Protara Therapeutics, Inc. 13G/A
TARA · 74365U107
3.9% 2/14/2025
Event 12/31/2024
Guardian Pharmacy Services, Inc. 13G/A
GRDN · 40145W101
4.5% 2/14/2025
Event 12/31/2024